Global Human Rabies Vaccine (Vero Cell) market size is predicted to grow from US$ 438 million in 2025 to US$ 593 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.

Global Human Rabies Vaccine (Vero Cell) Market Trends, Growth and Outlook 2025-31

The global Human Rabies Vaccine (Vero Cell) market size is predicted to grow from US$ 438 million in 2025 to US$ 593 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031. Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Human Rabies Vaccine (Vero Cell) Industry Forecast looks at past sales and reviews total world Human Rabies Vaccine (Vero Cell) sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Rabies Vaccine (Vero Cell) sales for 2025 through 2031. With Human Rabies Vaccine (Vero Cell) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Rabies Vaccine (Vero Cell) industry. This Insight Report provides a comprehensive analysis of the global Human Rabies Vaccine (Vero Cell) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Rabies Vaccine (Vero Cell) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Human Rabies Vaccine (Vero Cell) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Rabies Vaccine (Vero Cell) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Rabies Vaccine (Vero Cell). This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Vaccine (Vero Cell) market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 0.5ml &nbsp;&nbsp;&nbsp; 1ml Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Liaoning Chengda &nbsp;&nbsp;&nbsp; Guangzhou Nuocheng &nbsp;&nbsp;&nbsp; Ningbo Rongan &nbsp;&nbsp;&nbsp; Hualan Bio-vaccine &nbsp;&nbsp;&nbsp; Sanofi Pasteur SA &nbsp;&nbsp;&nbsp; Bharat Biotech &nbsp;&nbsp;&nbsp; Bavarian Nordic &nbsp;&nbsp;&nbsp; Serum Institute of India Pvt. &nbsp;&nbsp;&nbsp; Chengdu Kanghua Biology &nbsp;&nbsp;&nbsp; Changchun Zhuoyi Biology &nbsp;&nbsp;&nbsp; Dalian Yali Peak &nbsp;&nbsp;&nbsp; Jilin Huikang Biopharmaceutical Co., Ltd. Key Questions Addressed in this Report What is the 10-year outlook for the global Human Rabies Vaccine (Vero Cell) market? What factors are driving Human Rabies Vaccine (Vero Cell) market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Human Rabies Vaccine (Vero Cell) market opportunities vary by end market size? How does Human Rabies Vaccine (Vero Cell) break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Human Rabies Vaccine (Vero Cell) by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Human Rabies Vaccine (Vero Cell) by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Human Rabies Vaccine (Vero Cell) Segment by Type &nbsp;2.2.1 0.5ml &nbsp;2.2.2 1ml &nbsp;2.3 Human Rabies Vaccine (Vero Cell) Sales by Type &nbsp;2.3.1 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Human Rabies Vaccine (Vero Cell) Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Human Rabies Vaccine (Vero Cell) Sale Price by Type (2020-2025) &nbsp;2.4 Human Rabies Vaccine (Vero Cell) Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.5 Human Rabies Vaccine (Vero Cell) Sales by Application &nbsp;2.5.1 Global Human Rabies Vaccine (Vero Cell) Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Human Rabies Vaccine (Vero Cell) Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Human Rabies Vaccine (Vero Cell) Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Human Rabies Vaccine (Vero Cell) Breakdown Data by Company &nbsp;3.1.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Company (2020-2025) &nbsp;3.2.2 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Human Rabies Vaccine (Vero Cell) Sale Price by Company &nbsp;3.4 Key Manufacturers Human Rabies Vaccine (Vero Cell) Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Human Rabies Vaccine (Vero Cell) Product Location Distribution &nbsp;3.4.2 Players Human Rabies Vaccine (Vero Cell) Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Human Rabies Vaccine (Vero Cell) by Geographic Region &nbsp;4.1 World Historic Human Rabies Vaccine (Vero Cell) Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Human Rabies Vaccine (Vero Cell) Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Human Rabies Vaccine (Vero Cell) Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Human Rabies Vaccine (Vero Cell) Sales Growth &nbsp;4.4 APAC Human Rabies Vaccine (Vero Cell) Sales Growth &nbsp;4.5 Europe Human Rabies Vaccine (Vero Cell) Sales Growth &nbsp;4.6 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Growth 5 Americas &nbsp;5.1 Americas Human Rabies Vaccine (Vero Cell) Sales by Country &nbsp;5.1.1 Americas Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2025) &nbsp;5.1.2 Americas Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2025) &nbsp;5.2 Americas Human Rabies Vaccine (Vero Cell) Sales by Type (2020-2025) &nbsp;5.3 Americas Human Rabies Vaccine (Vero Cell) Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Human Rabies Vaccine (Vero Cell) Sales by Region &nbsp;6.1.1 APAC Human Rabies Vaccine (Vero Cell) Sales by Region (2020-2025) &nbsp;6.1.2 APAC Human Rabies Vaccine (Vero Cell) Revenue by Region (2020-2025) &nbsp;6.2 APAC Human Rabies Vaccine (Vero Cell) Sales by Type (2020-2025) &nbsp;6.3 APAC Human Rabies Vaccine (Vero Cell) Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Human Rabies Vaccine (Vero Cell) by Country &nbsp;7.1.1 Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2025) &nbsp;7.1.2 Europe Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2025) &nbsp;7.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Type (2020-2025) &nbsp;7.3 Europe Human Rabies Vaccine (Vero Cell) Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) by Country &nbsp;8.1.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Human Rabies Vaccine (Vero Cell) &nbsp;10.3 Manufacturing Process Analysis of Human Rabies Vaccine (Vero Cell) &nbsp;10.4 Industry Chain Structure of Human Rabies Vaccine (Vero Cell) 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Human Rabies Vaccine (Vero Cell) Distributors &nbsp;11.3 Human Rabies Vaccine (Vero Cell) Customer 12 World Forecast Review for Human Rabies Vaccine (Vero Cell) by Geographic Region &nbsp;12.1 Global Human Rabies Vaccine (Vero Cell) Market Size Forecast by Region &nbsp;12.1.1 Global Human Rabies Vaccine (Vero Cell) Forecast by Region (2026-2031) &nbsp;12.1.2 Global Human Rabies Vaccine (Vero Cell) Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Human Rabies Vaccine (Vero Cell) Forecast by Type (2026-2031) &nbsp;12.7 Global Human Rabies Vaccine (Vero Cell) Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Liaoning Chengda &nbsp;13.1.1 Liaoning Chengda Company Information &nbsp;13.1.2 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Liaoning Chengda Main Business Overview &nbsp;13.1.5 Liaoning Chengda Latest Developments &nbsp;13.2 Guangzhou Nuocheng &nbsp;13.2.1 Guangzhou Nuocheng Company Information &nbsp;13.2.2 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Guangzhou Nuocheng Main Business Overview &nbsp;13.2.5 Guangzhou Nuocheng Latest Developments &nbsp;13.3 Ningbo Rong'an &nbsp;13.3.1 Ningbo Rong'an Company Information &nbsp;13.3.2 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.3.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Ningbo Rong'an Main Business Overview &nbsp;13.3.5 Ningbo Rong'an Latest Developments &nbsp;13.4 Hualan Bio-vaccine &nbsp;13.4.1 Hualan Bio-vaccine Company Information &nbsp;13.4.2 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Hualan Bio-vaccine Main Business Overview &nbsp;13.4.5 Hualan Bio-vaccine Latest Developments &nbsp;13.5 Sanofi Pasteur SA &nbsp;13.5.1 Sanofi Pasteur SA Company Information &nbsp;13.5.2 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Sanofi Pasteur SA Main Business Overview &nbsp;13.5.5 Sanofi Pasteur SA Latest Developments &nbsp;13.6 Bharat Biotech &nbsp;13.6.1 Bharat Biotech Company Information &nbsp;13.6.2 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Bharat Biotech Main Business Overview &nbsp;13.6.5 Bharat Biotech Latest Developments &nbsp;13.7 Bavarian Nordic &nbsp;13.7.1 Bavarian Nordic Company Information &nbsp;13.7.2 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Bavarian Nordic Main Business Overview &nbsp;13.7.5 Bavarian Nordic Latest Developments &nbsp;13.8 Serum Institute of India Pvt. &nbsp;13.8.1 Serum Institute of India Pvt. Company Information &nbsp;13.8.2 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Serum Institute of India Pvt. Main Business Overview &nbsp;13.8.5 Serum Institute of India Pvt. Latest Developments &nbsp;13.9 Chengdu Kanghua Biology &nbsp;13.9.1 Chengdu Kanghua Biology Company Information &nbsp;13.9.2 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Chengdu Kanghua Biology Main Business Overview &nbsp;13.9.5 Chengdu Kanghua Biology Latest Developments &nbsp;13.10 Changchun Zhuoyi Biology &nbsp;13.10.1 Changchun Zhuoyi Biology Company Information &nbsp;13.10.2 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Changchun Zhuoyi Biology Main Business Overview &nbsp;13.10.5 Changchun Zhuoyi Biology Latest Developments &nbsp;13.11 Dalian Yali Peak &nbsp;13.11.1 Dalian Yali Peak Company Information &nbsp;13.11.2 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Dalian Yali Peak Main Business Overview &nbsp;13.11.5 Dalian Yali Peak Latest Developments &nbsp;13.12 Jilin Huikang Biopharmaceutical Co., Ltd. &nbsp;13.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Information &nbsp;13.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolios and Specifications &nbsp;13.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Main Business Overview &nbsp;13.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Latest Developments 14 Research Findings and Conclusion

Report	Global Human Rabies Vaccine (Vero Cell) Market Growth 2025-2031
Selected License	Multi ID: LPI38812

Buyer Information

Order Summary